SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-003722
Filing Date
2017-04-11
Accepted
2017-04-11 07:02:03
Documents
99
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2044608
2 ex31-1.htm EX-31.1 19768
3 ex31-2.htm EX-31.2 18065
4 ex32-1.htm EX-32.1 7881
5 ex32-2.htm EX-32.2 7425
  Complete submission text file 0001493152-17-003722.txt   6450623

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20161231.xml EX-101.INS 953366
7 XBRL SCHEMA FILE aker-20161231.xsd EX-101.SCH 72906
8 XBRL CALCULATION FILE aker-20161231_cal.xml EX-101.CAL 78430
9 XBRL DEFINITION FILE aker-20161231_def.xml EX-101.DEF 226886
10 XBRL LABEL FILE aker-20161231_lab.xml EX-101.LAB 455751
11 XBRL PRESENTATION FILE aker-20161231_pre.xml EX-101.PRE 362232
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36268 | Film No.: 17754871
SIC: 2835 In Vitro & In Vivo Diagnostic Substances